1 active not recruiting, 1 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Completed 1 |
Follow Unresectable Chordoma: new trials by email Literature Review of Unresectable Chordoma trials Research Report on Unresectable Chordoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cetuximab for the Treatment of Advanced Unresectable or Metastatic Chordoma Cetuximab, Questionnaire Administration - Chordoma, Metastatic Chordoma | Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 29 | 2022-05-27 | 2026-09-04 |
| Nivolumab and Relatlimab in Treating Participants With Advanced Chordoma Nivolumab, Relatlimab - Chordoma, Locally Advanced Chordoma | Phase 2 | Completed | Jonsson Comprehensive Cancer Center | 10 | 2019-04-03 | 2024-04-16 |
Chordoma (2)
Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Germ Cell and Embryonal (2)
Cetuximab (1) · Disulfides (1) · Immunoglobulin G (1) · Nivolumab (1) · relatlimab (1)
Jonsson Comprehensive Cancer Center (1) · M.D. Anderson Cancer Center (1)
United States (2)
Anthony P Conley, MD (1) · Arun Singh (1)